Overview

Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent

Status:
Completed
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
Examination of the effect of GET 73 on alcohol pharmacokinetics and pharmacodynamics (intoxication and sedation)and safety profile in alcohol-dependent individuals.To evaluate whether GET 73, as compared to placebo, results in diminished cue-reactivity responses to alcohol cues in terms of urge to drink during the cue reactivity session and results in lower quantity of alcohol consumed during an alcohol self-administration session.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Laboratorio Farmaceutico Ct S.r.l.
Collaborators:
Latis S.r.l.
Latis Srl
Quotient Bioresearch
Quotient Bioresearch Ltd
Voisin Consulting, Inc.
Treatments:
Ethanol